253 related articles for article (PubMed ID: 16050257)
1. Cell therapy for Parkinson's disease: problems and prospects.
Björklund A
Novartis Found Symp; 2005; 265():174-86; discussion 187, 204-211. PubMed ID: 16050257
[TBL] [Abstract][Full Text] [Related]
2. Engineering a dopaminergic phenotype in stem/precursor cells: role of Nurr1, glia-derived signals, and Wnts.
Arenas E
Ann N Y Acad Sci; 2005 May; 1049():51-66. PubMed ID: 15965107
[TBL] [Abstract][Full Text] [Related]
3. Stem cells may reshape the prospect of Parkinson's disease therapy.
Sonntag KC; Simantov R; Isacson O
Brain Res Mol Brain Res; 2005 Mar; 134(1):34-51. PubMed ID: 15790528
[TBL] [Abstract][Full Text] [Related]
4. Stem cell-based therapy for Parkinson's disease.
Correia AS; Anisimov SV; Li JY; Brundin P
Ann Med; 2005; 37(7):487-98. PubMed ID: 16278162
[TBL] [Abstract][Full Text] [Related]
5. Pattern of long-term sensorimotor recovery following intrastriatal and--accumbens DA micrografts in a rat model of Parkinson's disease.
Falkenstein G; Rosenthal C; Reum T; Morgenstern R; Döbrössy M; Nikkhah G
J Comp Neurol; 2009 Jul; 515(1):41-55. PubMed ID: 19399892
[TBL] [Abstract][Full Text] [Related]
6. Prospects of stem cell therapy for replacing dopamine neurons in Parkinson's disease.
Lindvall O; Kokaia Z
Trends Pharmacol Sci; 2009 May; 30(5):260-7. PubMed ID: 19362379
[TBL] [Abstract][Full Text] [Related]
7. The search for a curative cell therapy in Parkinson's disease.
Laguna Goya R; Tyers P; Barker RA
J Neurol Sci; 2008 Feb; 265(1-2):32-42. PubMed ID: 17936303
[TBL] [Abstract][Full Text] [Related]
8. Multitracer assessment of dopamine function after transplantation of embryonic stem cell-derived neural stem cells in a primate model of Parkinson's disease.
Muramatsu S; Okuno T; Suzuki Y; Nakayama T; Kakiuchi T; Takino N; Iida A; Ono F; Terao K; Inoue N; Nakano I; Kondo Y; Tsukada H
Synapse; 2009 Jul; 63(7):541-8. PubMed ID: 19253400
[TBL] [Abstract][Full Text] [Related]
9. From bench to bed: the potential of stem cells for the treatment of Parkinson's disease.
Morizane A; Li JY; Brundin P
Cell Tissue Res; 2008 Jan; 331(1):323-36. PubMed ID: 18034267
[TBL] [Abstract][Full Text] [Related]
10. Regenerative medicine in Parkinson's disease: generation of mesencephalic dopaminergic cells from embryonic stem cells.
Taylor H; Minger SL
Curr Opin Biotechnol; 2005 Oct; 16(5):487-92. PubMed ID: 16143504
[TBL] [Abstract][Full Text] [Related]
11. [Stem cells: solution to the problem of transplants in Parkinson's disease?].
Linazasoro G
Neurologia; 2003 Mar; 18(2):74-100. PubMed ID: 12610757
[TBL] [Abstract][Full Text] [Related]
12. Neural grafting in Parkinson's disease Problems and possibilities.
Brundin P; Barker RA; Parmar M
Prog Brain Res; 2010; 184():265-94. PubMed ID: 20887880
[TBL] [Abstract][Full Text] [Related]
13. Cell transplantation for patients with Parkinson's disease.
Paul G
Handb Exp Pharmacol; 2006; (174):361-88. PubMed ID: 16370335
[TBL] [Abstract][Full Text] [Related]
14. The role of Lmx1a in the differentiation of human embryonic stem cells into midbrain dopamine neurons in culture and after transplantation into a Parkinson's disease model.
Cai J; Donaldson A; Yang M; German MS; Enikolopov G; Iacovitti L
Stem Cells; 2009 Jan; 27(1):220-9. PubMed ID: 18832589
[TBL] [Abstract][Full Text] [Related]
15. Derivation of functional dopamine neurons from embryonic stem cells.
Kim DS; Kim JY; Kang M; Cho MS; Kim DW
Cell Transplant; 2007; 16(2):117-23. PubMed ID: 17474293
[TBL] [Abstract][Full Text] [Related]
16. Long-term survival and integration of porcine expanded neural precursor cell grafts in a rat model of Parkinson's disease.
Harrower TP; Tyers P; Hooks Y; Barker RA
Exp Neurol; 2006 Jan; 197(1):56-69. PubMed ID: 16246328
[TBL] [Abstract][Full Text] [Related]
17. Cell replacement therapy for Parkinson's disease: how close are we to the clinic?
Ganz J; Lev N; Melamed E; Offen D
Expert Rev Neurother; 2011 Sep; 11(9):1325-39. PubMed ID: 21864078
[TBL] [Abstract][Full Text] [Related]
18. Dopaminergic properties and function after grafting of attached neural precursor cultures.
Timmer M; Grosskreutz J; Schlesinger F; Krampfl K; Wesemann M; Just L; Bufler J; Grothe C
Neurobiol Dis; 2006 Mar; 21(3):587-606. PubMed ID: 16256357
[TBL] [Abstract][Full Text] [Related]
19. Olfactory mucosa is a potential source for autologous stem cell therapy for Parkinson's disease.
Murrell W; Wetzig A; Donnellan M; Féron F; Burne T; Meedeniya A; Kesby J; Bianco J; Perry C; Silburn P; Mackay-Sim A
Stem Cells; 2008 Aug; 26(8):2183-92. PubMed ID: 18535154
[TBL] [Abstract][Full Text] [Related]
20. Generation of graftable dopaminergic neuron progenitors from mouse ES cells by a combination of coculture and neurosphere methods.
Morizane A; Takahashi J; Shinoyama M; Ideguchi M; Takagi Y; Fukuda H; Koyanagi M; Sasai Y; Hashimoto N
J Neurosci Res; 2006 May; 83(6):1015-27. PubMed ID: 16493682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
